A detailed history of Ofi Invest Asset Management transactions in Moderna, Inc. stock. As of the latest transaction made, Ofi Invest Asset Management holds 1,193 shares of MRNA stock, worth $47,875. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,193
Previous 1,110 7.48%
Holding current value
$47,875
Previous $110 Million 20.69%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

BUY
$101.21 - $166.61 $8,400 - $13,828
83 Added 7.48%
1,193 $132 Million
Q3 2023

Nov 02, 2023

SELL
$96.41 - $126.61 $12.9 Million - $16.9 Million
-133,546 Reduced 99.18%
1,110 $108 Million
Q2 2023

Jul 31, 2023

SELL
$118.5 - $160.53 $2.52 Billion - $3.42 Billion
-21,299,497 Reduced 99.37%
134,656 $16.3 Billion
Q1 2023

May 15, 2023

BUY
$135.66 - $197.02 $2.91 Billion - $4.22 Billion
21,434,153 New
21,434,153 $3.29 Billion

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Ofi Invest Asset Management Portfolio

Follow Ofi Invest Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ofi Invest Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Ofi Invest Asset Management with notifications on news.